Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DOX-SL: Began three Phase II trials

Liposome Technology Inc. (LTIZ), Menlo Park, Calif.
Product: DOX-SL

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE